Skip to main content
. 2020 May 19;2020(5):CD011737. doi: 10.1002/14651858.CD011737.pub2

3. Number of participants and number of participants with data for continuous outcomes (by intervention arm).

  Participants Total cholesterol LDL cholesterol HDL cholesterol Triglycerides TG/HDL ratio Total cholesterol/HDL ratio LDL/HDL ratio LP (a) Insulin sensitivity
Black 1994 133 0 0 0 0 0 0 0 0 0
DART 1989 2033 1855 0 1855 0 0 0 0 0 0
Houtsmuller 1979 102 96 0 0 96 0 0 0 0 96
Ley 2004 176 103 103 103 103 0 103 0 0 103
Moy 2001 267 0 235 235 235 0 0 0 0 0
MRC 1968 393 177 0 0 0 0 0 0 0 0
Oslo Diet‐Heart 1966 412 329 0 0 0 0 0 0 0 0
Oxford Retinopathy 1978 249 58 0 0 0 0 0 0 0 0
Rose corn oil 1965 41 22 0 0 0 0 0 0 0 0
Rose olive 1965 39 24 0 0 0 0 0 0 0 0
Simon 1997 194 72 71 72 71 0 0 0 0 0
STARS 1992 55 50 50 50 50 0 50 50 50 50
Sydney Diet‐Heart 1978 458 458 0 0 458 0 0 0 0 0
Veterans Admin 1969 846 843 0 0 0 0 0 0 0 0
WHI with CVD 2006 2277 0 0 0 0 0 0 0 0 0
WHI 2006 48,835 2832 2832 2832 2832 0 2832 0 2832 2832
WINS 2006 2437 196 0 0 0 0 0 0 0 0
Total Participants 58952 7115 3291 5147 3845 0 2985 50 2882 3081
Percent of participants for this outcome 100% 12% 6% 9% 7% 0% 5% 0.1% 5% 5%

These numbers are the numbers of participants in each study who were available for assessment of outcomes within meta‐analysis (not necessarily the number of participants randomised within the trial).

HDL: high density lipoprotein
LDL: low density lipoprotein
Lp(a): lipoprotein (a)
TG: triglyceride